Zevra Therapeutics Says FDA Accepts Resubmission Of Arimoclomol NDA In Niemann-Pick Disease Type C

RTTNews | 656 gün önce
Zevra Therapeutics Says FDA Accepts Resubmission Of Arimoclomol NDA In Niemann-Pick Disease Type C

(RTTNews) - Rare disease therapeutics company Zevra Therapeutics, Inc. (ZVRA) announced Monday that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the New Drug Application (NDA) for arimoclomol as an orally-delivered, first-in-class treatment for Niemann-Pick disease type C.

Under the Prescription Drug User Fee Act (PDUFA), the FDA has deemed the arimoclomol NDA resubmission to be a Class II complete response which has a six-month review period from the date of resubmission.

As a result, the FDA has assigned a PDUFA action date of June 21, 2024, and currently intends to present the resubmission for discussion in an advisory committee.

Zevra believes that its resubmission of the arimoclomol NDA addresses the concerns previously raised in the June 2021 complete response letter (CRL) issued by the FDA in response to the prior arimoclomol NDA filing.

Etiketler: ZVRA
read more
Zevra Therapeutics Says FDA Extends NDA Review Period For Arimoclomol

Zevra Therapeutics Says FDA Extends NDA Review Period For Arimoclomol

Zevra Therapeutics, Inc. (ZVRA) announced Monday the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for arimoclomol, an investigational orally delivered, first-in-class treatment for Niemann-Pick disease type C (NPC).
RTTNews | 600 gün önce
Zevra Therapeutics Resubmits Arimoclomol NDA To FDA

Zevra Therapeutics Resubmits Arimoclomol NDA To FDA

Zevra Therapeutics, Inc. (ZVRA) announced Wednesday it resubmitted its New Drug Application (NDA) for arimoclomol to the U.S. Food and Drug Administration (FDA) on December 22, 2023. Arimoclomol is an investigational therapeutic candidate for the treatment of Niemann-Pick disease type C (NPC).
RTTNews | 668 gün önce
Russia Central Bank Cuts Rates For Fourth Policy Session

Russia Central Bank Cuts Rates For Fourth Policy Session

Russia's central bank unexpectedly reduced its key interest rate for the fourth policy session in a row, citing high inflation expectations and lackluster growth, and signaled that monetary policy will remain tight for an extended period of time.
RTTNews | 19s 58 dakika önce
Canadian Market Rises On Rate Cut Bets

Canadian Market Rises On Rate Cut Bets

The Canadian market is up firmly in positive territory Friday afternoon, thanks to strong gains in the technology sector. A few stocks from financial and communications sectors are also up with notable gains.
RTTNews | 22s 26 dakika önce
Swiss Market Ends Marginally Up After Choppy Ride

Swiss Market Ends Marginally Up After Choppy Ride

The market started off on a positive note on Friday but slipped into the red around mid morning and then struggled for direction till the end with stocks swinging between gains and losses amid cautious moves by investors.
RTTNews | 22s 56 dakika önce
European Stocks Close Higher After Cautious Session

European Stocks Close Higher After Cautious Session

Despite struggling for support till mid afternoon, European stocks edged higher on Friday after cooler-than-expected U.S. consumer price inflation raised prospects of an interest rate cut by the Federal Reserve next week.
RTTNews | 23s 21 dakika önce
U.S. Consumer Sentiment Deteriorates More Than Previously Estimated In October

U.S. Consumer Sentiment Deteriorates More Than Previously Estimated In October

Revised data released by the University of Michigan on Friday showed consumer sentiment in the U.S. deteriorated by more than initially estimated in the month of October. The University of Michigan said its consumer sentiment index was downwardly revised to 53.6 from the preliminary reading of 55.0. Economists had expected the consumer sentiment index to be unrevised from the preliminary reading.
RTTNews | 1 gün önce